Reducing Hospitalizations: Institution of Outpatient Infusional EPOCH-Based Chemotherapy at a Safety Net Hospital.

Q1 Nursing Journal of Oncology Practice Pub Date : 2019-08-01 Epub Date: 2019-06-17 DOI:10.1200/JOP.18.00738
Neil Keshvani, Mary Hon, Arjun Gupta, Timothy J Brown, Lonnie Roy, Eileen Marley, Sandy Lindsey, David H Johnson, Navid Sadeghi, Hsiao C Li
{"title":"Reducing Hospitalizations: Institution of Outpatient Infusional EPOCH-Based Chemotherapy at a Safety Net Hospital.","authors":"Neil Keshvani,&nbsp;Mary Hon,&nbsp;Arjun Gupta,&nbsp;Timothy J Brown,&nbsp;Lonnie Roy,&nbsp;Eileen Marley,&nbsp;Sandy Lindsey,&nbsp;David H Johnson,&nbsp;Navid Sadeghi,&nbsp;Hsiao C Li","doi":"10.1200/JOP.18.00738","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>EPOCH (etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin) -based chemotherapy is traditionally administered inpatient because of its complex 96-hour protocol and number of involved medications. These routine admissions are costly, disruptive, and isolating to patients. Here, we describe our experience transitioning from inpatient to outpatient ambulatory EPOCH-based chemotherapy in a safety-net hospital, associated cost savings, and patient perceptions.</p><p><strong>Methods and materials: </strong>Guidelines for chemotherapy administration and educational materials were developed by a multidisciplinary team of physicians, nurses, and pharmacists. Data were collected via chart review and costs via the finance department. Patient satisfaction with chemotherapy at home compared with hospitalization was measured on a Likert-type scale via direct-to-patient survey.</p><p><strong>Results: </strong>From January 30, 2017, through January 30, 2018, 87 cycles of EPOCH-based chemotherapy were administered to 23 patients. Sixty-one ambulatory cycles (70%) were administered to 18 patients. Of 26 cycles administered in the hospital, 18 (69%) were the first cycle of treatment. Rates of inappropriate prophylactic antimicrobial prescription and laboratory testing were lower in the outpatient setting. Eight of nine patients surveyed preferred home chemotherapy to inpatient chemotherapy. Per-cycle drug costs were 57.6% lower in outpatients as a result of differences in the acquisition cost in the outpatient setting. In total, the transition to ambulatory EPOCH-based chemotherapy yielded 1-year savings of $502,030 and an estimated 336 days of avoided hospital confinement.</p><p><strong>Conclusion: </strong>Multiday ambulatory EPOCH-based regimens were successfully and safely administered in our safety-net hospital. Outpatient therapy was associated with significant savings through avoided hospitalizations and reductions in drug acquisition cost and improved patient satisfaction.</p>","PeriodicalId":54273,"journal":{"name":"Journal of Oncology Practice","volume":"15 8","pages":"e644-e651"},"PeriodicalIF":0.0000,"publicationDate":"2019-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1200/JOP.18.00738","citationCount":"11","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Oncology Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1200/JOP.18.00738","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2019/6/17 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"Nursing","Score":null,"Total":0}
引用次数: 11

Abstract

Purpose: EPOCH (etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin) -based chemotherapy is traditionally administered inpatient because of its complex 96-hour protocol and number of involved medications. These routine admissions are costly, disruptive, and isolating to patients. Here, we describe our experience transitioning from inpatient to outpatient ambulatory EPOCH-based chemotherapy in a safety-net hospital, associated cost savings, and patient perceptions.

Methods and materials: Guidelines for chemotherapy administration and educational materials were developed by a multidisciplinary team of physicians, nurses, and pharmacists. Data were collected via chart review and costs via the finance department. Patient satisfaction with chemotherapy at home compared with hospitalization was measured on a Likert-type scale via direct-to-patient survey.

Results: From January 30, 2017, through January 30, 2018, 87 cycles of EPOCH-based chemotherapy were administered to 23 patients. Sixty-one ambulatory cycles (70%) were administered to 18 patients. Of 26 cycles administered in the hospital, 18 (69%) were the first cycle of treatment. Rates of inappropriate prophylactic antimicrobial prescription and laboratory testing were lower in the outpatient setting. Eight of nine patients surveyed preferred home chemotherapy to inpatient chemotherapy. Per-cycle drug costs were 57.6% lower in outpatients as a result of differences in the acquisition cost in the outpatient setting. In total, the transition to ambulatory EPOCH-based chemotherapy yielded 1-year savings of $502,030 and an estimated 336 days of avoided hospital confinement.

Conclusion: Multiday ambulatory EPOCH-based regimens were successfully and safely administered in our safety-net hospital. Outpatient therapy was associated with significant savings through avoided hospitalizations and reductions in drug acquisition cost and improved patient satisfaction.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
减少住院:在安全网医院门诊输液化疗的制度。
目的:EPOCH(依托泊苷、强的松、长春新碱、环磷酰胺和阿霉素)为基础的化疗由于其复杂的96小时方案和涉及的药物数量,传统上是住院患者使用的。这些常规的入院治疗费用昂贵,具有破坏性,对患者来说是孤立的。在这里,我们描述了我们的经验,从住院过渡到门诊门诊门诊epoch为基础的化疗在安全网医院,相关的成本节约,和病人的看法。方法和材料:化疗给药指南和教育材料是由医生、护士和药剂师组成的多学科团队制定的。数据通过图表审核收集,成本通过财务部门收集。通过直接对患者的调查,采用李克特量表测量患者对在家化疗与住院化疗的满意度。结果:2017年1月30日至2018年1月30日,23例患者接受了87个周期的epoch化疗。对18例患者进行61个动态周期(70%)治疗。在医院给予的26个周期中,18个(69%)是第一个治疗周期。不适当的预防性抗菌药物处方和实验室检测率在门诊较低。接受调查的9名患者中有8名更喜欢家庭化疗而不是住院化疗。门诊患者的每周期药物成本比门诊患者低57.6%,这是门诊患者获得成本差异的结果。总的来说,过渡到基于epoch的门诊化疗产生了1年的节省502,030美元,估计避免了336天的住院。结论:我院安全网医院实施了以epoch为基础的多日门诊治疗方案,效果良好,安全可靠。门诊治疗通过避免住院和减少药物获取成本以及提高患者满意度而显著节省费用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Oncology Practice
Journal of Oncology Practice Nursing-Oncology (nursing)
CiteScore
4.60
自引率
0.00%
发文量
0
期刊介绍: Journal of Oncology Practice (JOP) provides necessary information and insights to keep oncology practice current on changes and challenges inherent in delivering quality oncology care. All content dealing with understanding the provision of care—the mechanics of practice—is the purview of JOP. JOP also addresses an expressed need of practicing physicians to have compressed, expert opinion addressing common clinical problems.
期刊最新文献
Improving Documentation of Pain and Constipation Management Within the Cancer Center of a Large Urban Academic Hospital. Integrating Family Caregiver Support Into a Gynecologic Oncology Practice: An ASCO Quality Training Program Project. Impact of an Electronic Medical Record Alert on Code Status Documentation for Hospitalized Patients With Advanced Cancer. Employment Outcomes, Financial Burden, Anxiety, and Depression Among Caregivers of African American Cancer Survivors. Unpacking Trial Offers and Low Accrual Rates: A Qualitative Analysis of Clinic Visits With Physicians and Patients Potentially Eligible for a Prostate Cancer Clinical Trial.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1